PREVENTING AND RESPONDING TO HIV DRUG RESISTANCE IN THE AFRICAN REGION REGIONAL ACTION PLAN 2019-2023
Global action to combat HIV/AIDS has had an immense
impact in the African Region. By the end of 2017, 15.3
million people living with HIV (PLHIV) in the African
Region were accessing life-saving antiretroviral drugs (ARVs),
representing 70% of the 21.7 million people accessing
antiretrovirals (ARV) globally (1).
WHO and the Joint United Nations Programme on HIV/
AIDS (UNAIDS) have set the target of 90% of people living
with HIV on antiretroviral therapy (ART) achieving virological
Undefined
